KitoTech Medical Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • KitoTech Medical's estimated annual revenue is currently $2.5M per year.(i)
  • KitoTech Medical's estimated revenue per employee is $155,000

Employee Data

  • KitoTech Medical has 16 Employees.(i)
  • KitoTech Medical grew their employee count by -27% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$3.1M408%N/AN/A
#4
$5.1M336%N/AN/A
#5
$5.7M3742%N/AN/A
#6
$1.4M18-10%N/AN/A
#7
$5.4M3594%N/AN/A
#8
$34.5M17823%$30.2MN/A
#9
$1.1M70%N/AN/A
#10
$0.8M5-81%N/AN/A
Add Company

KitoTech Medical is a Seattle-based medical device company that has developed microMend, a unique wound closure device. The product is an FDA Class 1 medical device listed with FDA and available for sale in the United States. With innovation at the forefront of our mission, clinical studies are demonstrating outstanding clinical results and strong physician and patient preferences for microMend over sutures for closing wounds.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

KitoTech Medical's People

NameTitleEmail/Phone
1
Clinical Research ManagerReveal Email/Phone
2
President and CEOReveal Email/Phone
3
VP Sales & MarketingReveal Email/Phone
4
VP OperationsReveal Email/Phone

KitoTech Medical News

2022-04-06 - KitoTech Medical Signs Agreement with Corza Medical to ...

KitoTech Medical Signs Agreement with Corza Medical to Market microMend® PRO Wound Closure Devices in U.S.. By KitoTech Medical, Inc. Apr 12,...

2022-04-06 - KitoTech Medical Signs Agreement with Corza Medical to ...

KitoTech Medical, Inc. has entered a distribution agreement with Corza Medical, Inc. to sell the microMend® family of wound closure products...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M16N/AN/A
#2
$1.3M16N/AN/A
#3
$2.5M16-24%N/A
#4
$2.5M167%N/A
#5
$1.4M167%N/A